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Allergens or antigens when introduced on or in the 
skin may become localized at the surface of and in Lan-
gerhans cells (LCs). Langerhans cells are a strategically 
situated cell population able to migrate into lymphatics 
and lymph nodes. During the course of contact allergic 
reactions, they are apposed to lymphocytes; some LCs 
are injured by interaction with lymphocytes and by an-
tigen-antibody complexes plus complement. It is not yet 
clear to what extent these LCs may then release the 
substances they contain, such as enzymes from lyso-
somes, and cause further inflammatory changes. In con-
tact dermatitis they appear to play the role of antigen 
presenters, and may also be target cells and inflamma-
tion-producing cells. Since in contact allergy the major 
antigen presentation occurs via skin, it is likely that the 
presence of functional LCs with intact Ia antigens is of 
paramount importance for induction and elicitation of 
this immune response. 
Until recently, the function of Langerhans cells (LCs) has 
been a matter of conjecture. They were interpreted by some to 
be lymphoid cells capable of forming antibodies [1,2]. It was 
also proposed that they captured antigenic material and thus 
played a role in the primary immune response [3-5]. Some 
investigators proposed that LCs were epidermal macrophages 
[ 4,6,7]. 
The stimulus for this type of speculation in the absence of 
positive evidence was the work of Breathnach and Wyllie [8], 
who brought the finding of cells with LC granules in histiocy-
tosis X [9,10] to the attention of investigators in dermatology. 
Breathnach et al [11] disproved the neuroectodermal origin of 
LCs. Because of their work, investigators now relate LCs in 
some way to histiocytes. 
In our laboratory we examined LC behavior in immune 
responses in man and guinea pigs. Initially we observed close 
apposition (peripolesis) of mononuclear lymphocyte-like cells 
to LCs in man within 4 to 6 hr of topical application of mercury 
bichloride. This occurred only at sites of contact allergic hyper-
sensitivity reactions, and not at sites of contact primary irritant 
reactions [12-14]. Such observations suggested to us that the 
possible role of LCs in the pathogenesis of contact dermatitis 
needed more attention. Further experiments provided evidence 
that suggest LCs are the peripheral representation of a cell 
population that presents antigens to lymphocytes. 
In the sections that follow we will discuss the observations 
listed below. 
a. Langerhans cells pick up antigen in skin [15-18] and carry 
it by way of dermal lymphatics to draining lymph nodes 
[15] 
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b. There is apposition of lymphocyte-like cells to LCs in the 
epidermis and dermis in contact allergic dermatitis [12-
14,19] 
c. Langerhans cells are more active during contact allergic 
dermatitis (the evidence for this comprises prominent 
rough endoplasmic reticulum, Golgi areas, and the appear-
ance of vacuoles and lysosomes [14,15,19]) 
d. Langerhans cells are damaged during immune reactions 
[14,19,20] 
EVIDENCE LINKING LANGERHANS CELLS TO 
CONTACT ALLERGIC REACTIONS 
Ability of Langerhans Cell to Pick Up Antigen in Skin and 
Carry It by Way of Dermal Lymphatics to Draining Lymph 
Nodes 
The apposition of lymphocyte-like cells to LCs in contact 
allergic reactions suggested that some or all of the mononuclear 
cells apposed to LCs were specifically sensitized lymphocytes 
that interacted with antigen on or near the surfaces of the LCs 
[19]. To investigate this possibility, we conducted studies with 
ferritin by taking advantage of the fact that this antigen is 
detectable by electron microscopy. The studies showed that 
antigenic substances such as ferritin are indeed readily taken 
up by LCs and are seen on their swfaces and in membrane-
bound inclusions in their cytoplasm [15]. The distribution of 
ferritin molecules on and in the LCs appeared to be the same 
in ferritin-sensitized and nonsensitized animals. 
Shelley and Juhlin have demonstrated that LCs may selec-
tively absorb or remove the following compounds, each of which 
is a known potential cause of contact dermatitis: formaldehyde, 
glutaraldehyde, paraphenylenediamine, ethylenediamine, tolu-
enediamine, nickel, cobalt, chromium, mercury, and gold. They 
have suggested that these cells form a reticuloepithelial trap 
for ex_ternal contact allergens [16-18). Within 2 or 3 h:r after 
challenge in human beings with contact allergens similar to 
those used by these investigators, we have found a temporary 
increase in the number of recognizable LCs in the dermis at the 
sites of contact allergic reactions [14,21). Within a few hours 
after taking up antigens in skin, LCs carrying them are present 
in dermal lymphatics and in draining lymph nodes [15] (Fig 1). 
Although there appears to be a constant migration of LCs to 
lymph nodes in presumably nonreactive skin, the migration of 
both LCs and indeterminate dendritic cells (IDCs) from skin 
via dermal lymphatics to draining lymph nodes is much more 
readily seen at the site of challenge after topical or intradermal 
challenge of antigen in sensitized guinea pigs than in normal 
control animals (Table I) . This migration is multiplied by a 
factor of 3 to 7 in immunologically reactive skin [15]. Langer-
hans cells can-ying antigen have been seen in dermal lymphatics 
as eru·ly as 2 h:r after challenge [21]. The antigen-bearing 
function of LCs, similar to that of some macrophages [22], is 
resistant to 800-rad whole-body irradiation [15]. 
Although the lymph nodes of "normal" animals and of "nor-
mal" human beings rarely contain LCs [5,23], increased num-
bers of LCs are present in lymph nodes of sensitized animals, 
usually within 4 to 6 lu· but sometimes as eru·ly as 2 lu· after 
challenge. They have been observed in the marginal sinuses 
and cortexes, including the paracortical regions, of draining 
nodes. The fact that some LCs are present in paracortical 
regions suggests a possible interaction between LCs and T 
lymphocytes [15,24,25). Langerhans cells have been collected 
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FIG 1. A Langerhans cell (L) in the marginal sinus of a draining 
popli teal node of a ferritin-sensitive guinea pig 4 hr a fter intradermal 
challenge with 5 1-'g of fe rritin. Single arrow points to an aggregate of 
ferritin, and double arrows point to an LC granule. Prominent channels 
of rough endoplasmic reticulum (ER) are present (X 15,000). Top inset, 
ferrit in particles (X 240,000). Bottom inset, LC granule (X 120,000) . 
Reprinted, with permission from Silberberg-Sina kin et al [15]. 
TABLE I. Langerhans cell and indeterminate dendritic cell changes 
after dinitrochlorobenzene challenge in passively sensitized guinea 
pigs" 
Hours after 
DNCB 
cha Uenge 
2-6 
15-24 
LC changes 
LCs increased in epidermis" 
LCs increased in dermis; 50% 
apposed to lymphocyte-
like cells 
LCs increased also in dermal 
lymphatics' 
LCs decreased and damaged 
in epidermis; dermis not 
studied 
"Taken fro m reference 21. 
IDC changes 
IDCs increased in epi-
dermis 
IDCs not quantified in 
dermis 
IDCs increased in der-
mal lymphatics' 
IDCs increased in epi-
dermis;" dermis not 
studied 
" In epidermis of actively sensitized guinea pigs, LCs appeared to be 
decreased (21) . IDCs were not quantitated in the epidermis of these 
animals. 
' Seen more frequently at sites of contact a llergic reactions than in 
normal skin. 
" In the presence of a mononuclear cell infiltrate, other cells can look 
like IDCs; these IDCs do not necessarily represent the same cells called 
IDCs in normal skin . 
Abbreviations: DNCB, 2,4-dinitro-1-chlorobenzene; LC, Langerhans 
cell; IDC, indeterminate dendritic cell. 
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from afferent popliteal lymph in rabbits after regional antigenic 
stimulation. Increased numbers of cells travel from the site of 
antigenic stimulation to the regional nodes for a period of 
several days [26]. (The relationship between these cells and 
other interdigitating cells in lymph nodes is discussed elsewhere 
in this issue [27].) 
Apposition of Lymphocyte-Like Cells to Langerhans Cells 
Close apposition (peripolesis) of mononuclear lymphocyte-
like cells to LCs has been noted within 4 to 6 hr of topical 
application of such contact allergens as mercury bichloride, 
gold chloride, hexachlorophene, mercaptobenzothiazole, nick el 
sulfate, paraphenylenediamine, and pyrethrum to people with 
patch -test-proven contact hypersensitivity and not after topical 
application of primary irritants (sodium lauryl sulfate and soap) 
[14]. This apposition occurs in the epidermis and dermis (Fig 2 
and Table II) . These phenomena, initially observed in human 
beings, have also been noted in contact allergic guinea pigs, in 
studies with 2,4-dinitro-1-chlorobenzene (DNCB) [19,21]. At 
sites of challenge with DNCB in these animals, LCs can be seen 
apposed to lymphocyte-like cells (Fig 3 and Fig 4). Such appo-
sition in contact allergic reactions has also been seen in other 
laboratories [28,29]. Breathnach, elsewhere in this volume [30] 
, reports apposition of LCs to lymphocyte-like cells in the 
epidermis and dermis in clinically normal human skin. Thus 
there may be only a quantitative difference in the occurrenc~ 
FIG 2. Mononuclear cell (M) next to the dendrite of a Langerhans 
cell in a person. Arrow indicates a Langerhans cell granule. At the site 
of apposit ion in the cytoplasm of both cells there are ribosomes and 
inclusions resembling vesicles. Because of the rela tively large nucleus 
and scanty cytoplasm, the M resembles a lymphocyte. Section stained 
with uranyl acetate and lead citrate (X 11,500). Reprinted, with per-
mission, from Silberberg (14). 
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of this event in normal versus allergically reacting skin. Because 
we are not in an antigen-free environment, our skin is exposed 
almost constantly to a variety of antigens. DuTing contact 
allergic reactions there appears to be an amplification of LC-
lymphocyte apposition. 
TABLE II. Apposition of Langerhans cells to lymphocyte-lihe cells in 
human shin" 
Patch test sites studied' 
Positive contact allergic 
Positive contact irritant 
Negative contact 
"Taken from reference 14. 
Percentage of LCs apposed< 
b Examination of 21 positive allergic sites; 23 negative sites; and 5 
contact irritant reaction sites. 
c Determined on a minimum of 60 LCs counted per patch test site. 
d Exceptions to these findings were patch test sites clinically non-
reactive to mercUTic chloride; in these 10% of the LCs were apposed to 
lymphocyte-like cells. It had been postulated eru·lier that the property 
of mercUTic chloride, in certain concentrations, to nonspecifically trans-
form lymphocytes in vitro was related in some way to this phenomenon 
[14]. 
Abbreviation: LCs, Langerhans cells. 
FIG 3. Section 6 hr after dinitrochlorobenzene (DNCB) challenge in 
a guinea pig passively sensitized to DNCB. Two mononucleru· cells (M) 
with relatively large nuclei and small amounts of cytoplasm are seen in 
apposition to prut of a Langerhans cell (L ). These M resemble lym-
phocytes. Part of a nerve (N) and blood vessel containing an erythro-
cyte (B) ru·e visible. The L has damaged ceU membranes. It contains a 
single LC granule (arrow) . Section stained with uranyl acetate and 
lead citrate (X 12,250). Inset, enlargement of an LC granule. Pru·t of an 
M is touching the L (X 45,500). Reprinted, with permission, from 
Silberberg et al [21 ]. 
FIG 4. Langerhans cell (L) in the dermis of a guinea pig. The 
prominent feature of th is L is the rough endoplasmic reticulum (R) , 
which is shown together with an LC granule in the inset. Arrows point 
to LC granules. A lysosome-like body ( V) is present. A mononuclear 
cell (M) with several channels of R is in apposition to the L. This 
sample was taken 3 hr after dinitrochlorobenzene (DNCB) challenge in 
a guinea pig passively sensitized to DNCB. Section stained with W'anyl 
acetate and lead citrate (X 15,750). Inset, x 32,500. Reprinted, with 
permission from Silberberg et al [21]. 
Increased Activity of Langerhans Cells Signified by 
Prominent Rough Endoplasmic Reticulum, Golgi Areas, 
Vacuoles, and Lysosomes 
Morphological findings indicate that some LCs have secre-
tory functions in these contact hypersensitivity reactions 
[14,15,19,21]. A typical LC contains rough endoplasmic reticu-
lum, a prominent Golgi area, gray bodies, and vacuoles (Fig 4 
and Fig 5). It is of interest to speculate about a secretory 
function of LCs in relation to reports of prostaglandin activity 
at sites of contact dermatitis. This activity is due to prostaglan-
dins E and F [31,32]. The major portion of prostaglandin 
activity appears to be in the epidermis rather than in the dermis 
[33,34]. The mononuclear phagocyte has been suggested as the 
principal hemopoietic cell soUTce of prostaglandin E [35,36]. 
The formation of vacuoles in macrophages, resembling those 
seen in LCs (e.g., the LC in Fig 5), is reported to coincide with 
prostaglandin formation and has been postulated to be the 
result of the fusion of different cell organelles and the ensuing 
increased contact of the enzymes with their respective sub-
strates [3.6]. Therefore, if LCs represent the mononuclear phag-
ocyte system in the epidermis, they are likely to be an important 
SOU1'Ce of prostaglandins in skin. FUTther evidence that the LC 
64 SILBERBERG-SIN AKIN & THORBECKE 
FIG 5. Langerhans cell in the epidermis of a person with chronic 
contact dermatitis. In the cell cytoplasm there are several vacuoles ( V) 
that resemble those seen in macrophages found coincidentally with 
prostaglandin release [36]. There are also ribosomes (R) and channels 
of rough endoplasmic reticulum · (ER) filled with moderately opaque 
material. The Golgi region (G) is prominent. The area containing 
Langerhans cell granules is demarcated by lines. A lymphocyte-like cell 
(M) is apposed to the Langerhans cell. Section stained with uranyl 
acetate and lead citrate (X 12,000). Inset, Langerhans cell granules 
(arrows ) (X 25,000). Reprinted, with permission, from Silberberg [14]. 
may be a source of prostaglandins in skin has been discussed 
elsewhere [37]. Since catecholamines are known to represent 
an initial trigger of a cycle of events leading to prostaglandin 
synthesis [38], it seems possible that the affinity of catechol-
amines for LCs [39,40] is related to this postulated prostaglan-
din secretion. 
Damage of Langerhans Cells during Immune Reactions 
There is additional evidence that LCs undergo other changes 
as a result of local immune reactions. There is spotty damage 
in LCs and a decrease in their number in the epidermis in 
contact allergic reaction sites (Table I, Fig 6, and Fig 7) 
[14,19,21]. As early as 6 hr after antigen challenge in a contact-
sensitive host, some LCs show ultrastructural signs of cell 
damage (Fig 3). Within 48 hr after antigen challenge, some LCs 
contain membrane-bound inclusions that may represent auto-
phagic vacuoles (Fig 6), and macrophages are present with 
phagocytic vacuoles containing LC granules (Fig 7). Hunziker 
and Winkelmann [29] found an upward displacement of LCs in 
the epidermis and a total loss within 48 hr of ATPase-positive 
cells, but they did not study the dermis in detail. They suggested 
that the LCs were lost in the parakeratotic horny layer that 
was shed. Although the changes probably vary with the inten-
sity of the contact sensitivity, our results suggest that LCs may 
still be present but badly damaged. 
Not only is there damage to LCs in the later phase of contact 
allergic dermatitis, but also similar damage can be produced by 
immune complexes [20]. In experiments in which immune com-
plexes were injected into skin of normal, cobra-venom-extract-
treated, and C4-deficient guinea pigs, complement was needed 
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for this LC damage to occur [20]. The cell damage included th e 
presence of membrane-limited inclusions with the typical ap-
pearance of autophagic vacuoles; damaged mitochondria; dis-
rupted cell membranes; and lipid droplets. Even when the 
antigen-antibody complexes were bound to the LCs, the phag-
ocytic activities of the LCs were less than in classical macro-
phages [20]. 
ROLE OF LANGERHANS CELLS IN THE 
PATHOGENESIS OF CONTACT HYPERSENSITIVITY 
In summary, within about 2 to 3 hr after DNCB or ferritin 
challenge in guinea pigs, several changes occur in LCs: the 
number of recognizable LCs in skin increases; antigen is local-
ized on the surfaces and in membrane-bound organelles of LCs 
in skin; LCs show increased activity, i.e., prominent endoplas-
mic reticulum, Golgi areas, and lysosomes; in hosts with delayed 
hypersensitivity reactions, lymphocyte-like cells become ap-
posed to LCs in skin; and LCs enter dermal lymphatics and 
circulate to regional lymph nodes. 
Within about 4 to 6 hr after DNCB or ferritin challenge one 
may see: LCs in dermal lymphatics; increased numbers of LCs 
in marginal sinuses and cortexes, including the paracort ical 
areas, of regional lymph nodes; LCs in apposition to lympho-
cytes in the cortexes of lymph nodes; increased numbers of 
lymphocyte-like cells apposed to LCs in skin of hosts with 
delayed hypersensitivity reactions; and ultrastructural signs of 
cell damage within 6 to 12 hr in some LCs in skin of hosts with 
delayed hypersensitivity reactions. 
FIG 6. Contact allergic reaction in a guinea pig at 48 hr. A cell 
morphologically compatible with a Langerhans cell is shown. The 
arrow indicates a Langerhans cell granule. Several phagocyte vacuoles 
( V) are present in the cytoplasm. Section stained with uranyl acetate 
and lead citrate (X 19,500). Inset, Langerhans cell granule (X 32,500). 
Reprinted, with permission, from Silberberg et al [19]. 
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FIG 7. Contact allergic reaction in a guinea pig at 48 hr. Note the 
macrophage (MA) and several phagocytic vacuoles ( V). Some of these 
(arrow) contain Langerhans cell granules. Section stained with uranyl 
acetate and lead citrate (X 15,500). Inset, a V containing Langerhans 
cell granules (arrows) (X 104,000). Reprinted, with permission, from 
Silberberg et aJ [19]. 
Within about 19 or 24 hr after antigen challenge, the numbers 
of recognizable LCs are decreased in skin of hosts with delayed 
hypersensitivity reactions, LCs are present in the dermal lym-
phatics, and some LCs are present in the upper layers of the 
epidermis [29). After 48 hr, LCs can still be found in dermal 
lymphatics and still show damage. 
Because of their strategic locations in skin, LCs may be 
regarded as the fi·ont line of defense for the body. They form a 
relay system to the lymph nodes. Migration of LCs appears to 
be more active during immunologic reactions in skin [15] and 
appears to involve antigen-bearing LCs. Since these cells make 
up 3 to 8% of the epidermal cell population [ 41] and each cell 
may possess up to 12 dendrites [ 42], one can appreciate that 
the cells are well distributed and quite able to carry out their 
immunologic functions. On the basis of the experimental data 
reviewed above, one may infer that, upon introduction of aller-
gens or antigens on or in the skin, such substances may become 
localized at the surfaces of and in LCs. Langerhans cells can 
then present these substances to lymphocytes in the epidermis, 
dermis, dermal lymphatics, and lymph nodes. 
Events in Subjects Not Previously Sensitized 
If an animal has not been previously sensitized, exposme to 
antigen on LCs may set in motion the induction of delayed 
hypersensitivity, which in mice is known to be a function of the 
Ly 1+2- subclass ofT lymphocytes [43,44]. In line with this 
interpretation is the finding, by several investigators, of recep-
tors for IgG, of C3, and of Ia antigen on LCs [ 45-49], as well as 
the .finding that !a-bearing LCs can replace the antigen-pre-
senting subpopulation of macrophages in vitro [50]. It is prob-
able that a major mechanism in the induction of contact sen-
sitivity is via direct conjugation of sensitizing agents on LCs 
locally in skin. The hapten-LC complex would then serve as 
the inducing and eliciting antigen complex in contact dermatitis. 
However, formation of a hapten-keratinocyte complex that gets 
presented to lymphoid cells via LCs is an equally good possi-
bility. In contrast, exposure to a contact sensitizer through 
escape of the allergen from skin directly into the general cir-
culation [51], through ingestion [52], or intravenously [53,54] 
might lead to tolerance [55-57]. Exposme by these routes might 
bypass the LC system, and thus the appropriate presentation 
of antigen by LCs to the Ly 1 +2- subclass of lymphocytes might 
not take place [58]. If antigen is presented separately from the 
correct Ia antigens, suppressor T cell proliferation may result 
rather than helper T cell proliferation [59]. Destruction of Ia 
antigens on LCs or of LCs themselves would interfere with the 
induction and elicitation of contact allergic reactions. 
It has been noted in ·in vitro experiments that ultraviolet 
light (UVL) destroys the ability of lymphoid cells to induce 
mixed lymphocyte reactions, and this effect has been related to 
the destruction of Ia antigen [60,61]. It may be relevant that 
there is a decreased response to sensitization with DNCB in 
sun-damaged skin since it has been reported that a greater 
concentration of DNCB is needed to elicit a response to DNCB 
in sun-damaged skin than in normal skin. However, the amount 
of primary irritant substances needed to elicit a response in 
sun-damaged skin does not differ from the amount needed to 
elicit a response in normal skin. It has therefore been suggested 
that UVL can suppress immunity [62]. It is possible that the 
mechanism of suppression is by damage to Ia antigen on LCs 
or damage to LCs themselves, which in tmn interferes with the 
antigen-presenting properties of these cells. Of importance in 
this regard are experiments in which UVL irradiation caused a 
transient anergy to DNCB in mice. The temporary inability of 
UVL-treated mice to respond to DNCB seems to be due to a 
block in antigen processing or presentation since DNCB-reac-
tive lymphocytes have been found in mice in passive transfer 
studies [63] (see also the article by Toews, Bergstresser, and 
Streilein [64] in this issue). 
Events in Subjects Previously Sensitized 
In an animal that has been previously sensitized, exposure to 
the ·antigen on LCs may lead to blast formation, proliferation of 
sensitized cells, and probably the release of lymphokines. 
Whether lymphocytes such as killer T cells, lymphokines, or 
antigen-antibody complexes plus complement cause the dam-
age to LCs observed dming contact sensitivity reactions in skin 
is not clear [58]. The injmed LCs themselves, in turn, may 
release the substances they contain, perhaps including prosta-
glandins and enzymes fi·om lysosomes, and thus cause further 
inflammatory changes in the surrounding epidermis and dermis. 
In this type of immunologic reaction LCs have the potential of 
being antigen carriers, elicitors, target cells, and inflammation-
producing cells. 
The events that occm in skin of hosts with delayed hyper-
sensitivity reactions after challenge with antigenic substances 
appear to depend on several factors, among them the route of 
exposme (e.g., contact 01: intradermal injection) , the challenge 
dose, and the immunologic state of the animal (e.g. , cell-me-
diated and antibody-mediated hypersensitivity or the presence 
of immune complexes). The presence of Fe receptors on LCs 
may mediate the binding of antigen-antibody complexes to the 
smfaces of LCs. If the damage to LCs is not severe, they. can 
repair themselves by autophagy and circulate from skin to 
draining lymph nodes (Fig 6). When damage is severe, they are 
Hkely to b·e lysed. Under such circumstances, remnants of LCs, 
including LC granules, can be found in macrophages (Fig 7). 
The finding that immune complexes, in the presence of com-
plement, can damage LCs suggests a means by which an ac-
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quired local deficiency in the LC system can be produced [20). 
In the presence of sufficient quantities of immune complexes 
and of complement, damage to the LC system might be severe 
enough to interfere with the functions of LCs in cell-mediated 
reactions. The finding that LCs themselves are injured in some 
hypersensitivity reactions suggests that this phenomenon may 
be part of a homeostatic mechanism to prevent hyperstimula-
tion of certain immune responses [58). 
It was expected that the 1st epidermal histological changes 
in contact allergic dermatitis would be seen in the upper portion 
of the prickle cell layers. Instead they were seen in the middle 
and lower portions, possibly an indication of LC involvement. 
The release of damaging substances from sensitized lympho-
cytes and from LCs participating in the reaction could account 
for the localization of early lesions in the epidermis and dermis 
[37,58]. In response to antigen fixed to the surfaces of LCs, 
lymphoid cells could release lymphokines or respond cytotoxi-
cally and thereby cause damage to the LCs. Moreover, immune 
complexes plus complement might damage LCs. Further exper-
iments are needed to determine the exact mechanism by which 
LCs are damaged and the degree to which this damage contrib-
utes to epidermal changes such as edema, spongiosis, vesicula-
tion, bulla formation, and urtication [37,58]. 
PRECURSORS OF LANGERHANS CELLS IN 
CONTACT HYPERSENSITIVITY 
There are 3 possible explanations for the rapid accumulation 
(i.e., within 2 to 3 h.r) of LCs at sites of certain contact allergic 
reactions. First, pre-LCs may enter skin rapidly from the cir-
culation and become locally differentiated. Second, IDCs, func-
tioning as "pre-LCs," may start to form Birbeck granules. Third, 
LCs may become more readily detectable ultrastructurally be-
cause they contain more granules. In the epidermis, IDCs share 
the property of bearing Ia antigens [65]. Breathnach [66] has 
suggested that IDCs may have the latent capacity to produce 
Birbeck granules to a variety of stimuli and thus may be 
precursors of LCs. 
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The 8th Annual Pediatric Dermatology Seminar will convene at the Eden Roc Hotel, Miami Beach, 
Florida, February 26-MaTch 1, 1981. It will be followed by a 12 day postseminaT tow- to Tahiti and New 
Zealand with an optional extension to AustTalia. For information, contact: Guinter Kahn, M.D., 16800 
N.W. 2nd Ave., Miami, Florida 33169 (305-652-8600). 
